Oxford
Gene Technology
(OGT), provider of innovative clinical
genetics and diagnostic solutions to advance molecular medicine, has today
announced a collaborative agreement with Abcodia, a specialist company engaged
in the validation and discovery of biomarkers of cancer and other age-related diseases,
aimed at improving the early detection of pancreatic cancer. As part of this
collaboration, Abcodia will provide access to its large prospective serum
biobank, to harness samples taken from individuals up to 7 years before the
diagnosis of pancreatic cancer. OGT will apply its functional
protein array platform and its
GenefficiencyTM microRNA profiling array
to identify pancreatic cancer specific biomarkers that can be used as
diagnostic indicators of developing pancreatic cancer. Both OGT and Abcodia
will bring their expertise in experimental design and analysis.
At
present, the prognosis for someone diagnosed with pancreatic cancer is poor.
The limitations of current diagnostic techniques mean that often the cancer is
not detected until after it has spread. The identification of sensitive and
specific biomarkers that allow early detection of pancreatic cancer could
therefore significantly increase survival rates.
Julie
Barnes, Chief Executive Officer, Abcodia said: "We are very excited to be
able to form this strategic partnership with OGT. The combination of the
breadth of the OGT technology with our unique serum biobank provides a real
opportunity to significantly advance the field of early pancreatic cancer
diagnosis and screening."
John
Anson, Vice President Biomarker Discovery, OGT commented: "A common
challenge in discovering novel cancer biomarkers is the availability of well
characterised samples for the disease area of interest. We are delighted that,
through our partnership with Abcodia, we are able to employ our unique and
integrated genomic and proteomic array technologies to identify sensitive and
specific biomarkers for pancreatic cancer."
Financial
details of the partnership were not disclosed.
For more information about
OGT's cytogenetic, genomic and biomarker solutions visit
www.ogt.co.uk.
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.